Compelling 24.1-month median follow-up data presented at SITC 2024 showed that all patients treated with TG4050 after completion of an adjuvant ...

All treatment-related adverse events continue to be mild to moderate. Pr. Le Tourneau, head of the department of drug development and innovation (D3i) at Institut Curie, and Principal Investigator, ...

Whether you’ve inherited a Rolex from a family member, received one as a gift, or bought one for yourself years ago and simply no longer want it, selling it for some cold hard cash is much better than ...